These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 36010271)

  • 1. New Entity-Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement.
    Carsote M; Vasiliu C; Trandafir AI; Albu SE; Dumitrascu MC; Popa A; Mehedintu C; Petca RC; Petca A; Sandru F
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Liver Iron Concentrations (LIC) in 24 Patients with β-Thalassemia Major: Correlations with Serum Ferritin, Liver Enzymes and Endocrine Complications.
    Kanbour I; Chandra P; Soliman A; De Sanctis V; Nashwan A; Abusamaan S; Moustafa A; Yassin MA
    Mediterr J Hematol Infect Dis; 2018; 10(1):e2018062. PubMed ID: 30416694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major.
    Casale M; Citarella S; Filosa A; De Michele E; Palmieri F; Ragozzino A; Amendola G; Pugliese U; Tartaglione I; Della Rocca F; Cinque P; Nobili B; Perrotta S
    Am J Hematol; 2014 Dec; 89(12):1102-6. PubMed ID: 25197009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC.
    Soliman AT; Yassin MA; De Sanctis V
    Acta Biomed; 2018 Feb; 89(2-S):27-32. PubMed ID: 29451226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild subclinical hypothyroidism in thalassaemia major: prevalence, multigated radionuclide test, clinical and laboratory long-term follow-up study.
    De Sanctis V; De Sanctis E; Ricchieri P; Gubellini E; Gilli G; Gamberini MR
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():174-80. PubMed ID: 19337174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
    Gamberini MR; De Sanctis V; Gilli G
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content.
    Yassin MA; Soliman AT; De Sanctis V; Yassin KS; Abdulla MA
    Mediterr J Hematol Infect Dis; 2019; 11(1):e2019026. PubMed ID: 31205630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone - insulin-like growth factor-I axis and bone mineral density in adults with thalassemia major.
    Soliman A; De Sanctis V; Yassin M; Abdelrahman MO
    Indian J Endocrinol Metab; 2014 Jan; 18(1):32-8. PubMed ID: 24701427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
    Moayeri H; Oloomi Z
    Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth and Endocrine Function in Tunisian Thalassemia Major Patients.
    Dhouib NG; Ben Khaled M; Ouederni M; Besbes H; Kouki R; Mellouli F; Bejaoui M
    Mediterr J Hematol Infect Dis; 2018; 10(1):e2018031. PubMed ID: 29755708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-thalassemia.
    Galanello R; Origa R
    Orphanet J Rare Dis; 2010 May; 5():11. PubMed ID: 20492708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron Overload Associated Endocrine Dysfunction Leading to Lower Bone Mineral Density in Thalassemia Major.
    Yang WP; Chang HH; Li HY; Lai YC; Huang TY; Tsai KS; Lin KH; Lin DT; Jou ST; Lu MY; Yang YL; Chou SW; Shih SR
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31907538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective study on long-term effects of hormone replacement therapy (HRT) and iron chelation therapy on glucose homeostasis and insulin secretion in female ß- thalassemia major (β-TM) patients with acquired hypogonadotropic- hypogonadism (AHH).
    De Sanctis V; Daar S; Soliman A; Tzoulis P; Di Maio S; Kattamis C
    Acta Biomed; 2023 Aug; 94(4):e2023195. PubMed ID: 37539597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
    Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
    Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth hormone and adrenal response to intramuscular glucagon test and its relationship to IGF-1 production and left ventricular ejection fraction in adult B-thalassemia major patients.
    De Sanctis V; Skordis N; Galati MC; Raiola G; Giovannini M; Candini G; Kaffe K; Savvides I; Christou S
    Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():290-4. PubMed ID: 21705980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping.
    Khalifa AS; Salem M; Mounir E; El-Tawil MM; El-Sawy M; Abd Al-Aziz MM
    Pediatr Diabetes; 2004 Sep; 5(3):126-32. PubMed ID: 15450007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
    Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired Hypogonadotropic Hypogonadism (AHH) in Thalassaemia Major Patients: An Underdiagnosed Condition?
    De Sanctis V; Elsedfy H; Soliman AT; Elhakim IZ; Pepe A; Kattamis C; Soliman NA; Elalaily R; El Kholy M; Yassin M
    Mediterr J Hematol Infect Dis; 2016; 8(1):e2016001. PubMed ID: 26740862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose homeostasis in Egyptian children and adolescents with β-Thalassemia major: Relationship to oxidative stress.
    Metwalley KA; El-Saied AR
    Indian J Endocrinol Metab; 2014 May; 18(3):333-9. PubMed ID: 24944927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.